Current Environment: Production

English | Education

Undergraduate School

Harvard College

1983, Cambridge, MA

Medical School

Harvard Medical School

1991, Boston, MA

Internship

Massachusetts General Hospital

1992, Boston, MA

Residency

Massachusetts General Hospital

1997, Boston, MA

Fellowship

Boston Children's Hospital

1999, Boston, MA

Fellowship

Massachusetts General Hospital

1999, Boston, MA

English | Publications

  1. Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective. Pulm Circ. 2025 Jul; 15(3):e70126. View Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective. Abstract

  2. Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study. AAPS J. 2025 Jun 27; 27(5):114. View Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study. Abstract

  3. Anxiety and Depression Screening of Youth in Pediatric Pulmonary Hypertension Clinic: A Multi-Center, Cross-Sectional Study. Pulm Circ. 2025 Apr; 15(2):e70117. View Anxiety and Depression Screening of Youth in Pediatric Pulmonary Hypertension Clinic: A Multi-Center, Cross-Sectional Study. Abstract

  4. Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2025 Feb; 211(2):157-173. View Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. Abstract

  5. SOX17-Associated Pulmonary Hypertension in Children: A Distinct Developmental and Clinical Syndrome. J Pediatr. 2025 Mar; 278:114422. View SOX17-Associated Pulmonary Hypertension in Children: A Distinct Developmental and Clinical Syndrome. Abstract

  6. Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension. J Pediatr. 2025 Feb; 277:114383. View Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension. Abstract

  7. An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease. Eur Respir J. 2024 Sep; 64(3). View An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease. Abstract

  8. Correlation of Transthoracic Echocardiographic Estimates of Right Ventricular Pressure with Right Ventricular Pressure Measurements on Cardiac Catheterization in Children with Pulmonary Hypertension. J Cardiothorac Vasc Anesth. 2024 Dec; 38(12):3101-3108. View Correlation of Transthoracic Echocardiographic Estimates of Right Ventricular Pressure with Right Ventricular Pressure Measurements on Cardiac Catheterization in Children with Pulmonary Hypertension. Abstract

  9. Disparities in Healthcare Utilization: An Analysis of Disease Specific and Patient Level Factors in a Congenital Diaphragmatic Hernia Clinic. J Pediatr Surg. 2024 Oct; 59(10):161569. View Disparities in Healthcare Utilization: An Analysis of Disease Specific and Patient Level Factors in a Congenital Diaphragmatic Hernia Clinic. Abstract

  10. Exercise-Induced Pulmonary Hypertension in Long-Term Survivors of Congenital Diaphragmatic Hernia. J Pediatr. 2024 Aug; 271:114034. View Exercise-Induced Pulmonary Hypertension in Long-Term Survivors of Congenital Diaphragmatic Hernia. Abstract

  11. Childhood Pulmonary Embolism: Characterizing a Critical and Challenging Diagnosis. JACC Adv. 2024 Apr; 3(4):100896. View Childhood Pulmonary Embolism: Characterizing a Critical and Challenging Diagnosis. Abstract

  12. Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trials. Pulm Circ. 2024 Jan; 14(1):e12339. View Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trials. Abstract

  13. Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension. Pulm Circ. 2023 Oct; 13(4):e12305. View Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension. Abstract

  14. Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension. J Pediatr. 2023 11; 262:113639. View Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension. Abstract

  15. Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain. Pediatr Cardiol. 2024 Oct; 45(7):1573-1580. View Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain. Abstract

  16. Long-Term Functional Outcomes at 1-Year After Hospital Discharge in Critically Ill Neonates With Congenital Diaphragmatic Hernia. Pediatr Crit Care Med. 2023 08 01; 24(8):e372-e381. View Long-Term Functional Outcomes at 1-Year After Hospital Discharge in Critically Ill Neonates With Congenital Diaphragmatic Hernia. Abstract

  17. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not? Chest. 2023 09; 164(3):717-726. View Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not? Abstract

  18. Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes. J Pediatr. 2023 07; 258:113404. View Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes. Abstract

  19. Molecular Function and Contribution of TBX4 in Development and Disease. Am J Respir Crit Care Med. 2023 04 01; 207(7):855-864. View Molecular Function and Contribution of TBX4 in Development and Disease. Abstract

  20. An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. NPJ Genom Med. 2023 Mar 06; 8(1):7. View An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. Abstract

  21. JACC:Advances. Metabolomics in Single Ventricle Heart Disease: Glimpsing the Pathobiology of Stage 2 Palliation. 2023; 2(1). View JACC:Advances Abstract

  22. Metabolomics in Single Ventricle Heart Disease: Glimpsing the Pathobiology of Stage 2 Palliation. JACC Adv. 2023 Jan; 2(1):100170. View Metabolomics in Single Ventricle Heart Disease: Glimpsing the Pathobiology of Stage 2 Palliation. Abstract

  23. Understanding Genotype-Phenotype Correlations in Patients with TBX4 Mutations: New Views Inside and Outside the Box. Am J Respir Crit Care Med. 2022 12 15; 206(12):1448-1449. View Understanding Genotype-Phenotype Correlations in Patients with TBX4 Mutations: New Views Inside and Outside the Box. Abstract

  24. Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension. Am J Respir Crit Care Med. 2022 09 15; 206(6):664-665. View Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension. Abstract

  25. Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. J Pediatr. 2023 01; 252:131-140.e3. View Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. Abstract

  26. Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring. Pulm Circ. 2022 Jul; 12(3):e12121. View Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring. Abstract

  27. Outcomes for Children With Pulmonary Hypertension Undergoing Tracheostomy Placement: A Multi-Institutional Analysis. Pediatr Crit Care Med. 2022 09 01; 23(9):717-726. View Outcomes for Children With Pulmonary Hypertension Undergoing Tracheostomy Placement: A Multi-Institutional Analysis. Abstract

  28. Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension. Ann Am Thorac Soc. 2022 06; 19(6):1000-1012. View Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension. Abstract

  29. Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease. Pediatr Crit Care Med. 2022 09 01; 23(9):e440-e450. View Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease. Abstract

  30. Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2022 08; 27(4):101351. View Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia. Abstract

  31. Supraventricular Tachycardia in Infants With Congenital Diaphragmatic Hernia: Prevalence, Associations, and Outcomes. Pediatr Crit Care Med. 2022 07 01; 23(7):e329-e337. View Supraventricular Tachycardia in Infants With Congenital Diaphragmatic Hernia: Prevalence, Associations, and Outcomes. Abstract

  32. Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension. Pediatr Transplant. 2022 06; 26(4):e14236. View Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension. Abstract

  33. Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure?. Int J Cardiol Congenit Heart Dis. 2022 Mar; 7. View Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure?. Abstract

  34. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur Respir J. 2022 01; 59(1). View Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Abstract

  35. High altitude simulation testing in patients with congenital diaphragmatic hernia. J Pediatr Surg. 2022 Feb; 57(2):195-198. View High altitude simulation testing in patients with congenital diaphragmatic hernia. Abstract

  36. Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. J Pediatr. 2022 02; 241:68-76.e3. View Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. Abstract

  37. Isolation and Culturing Primary Chaolangiocytes from Mouse Liver. Bio Protoc. 2021 Oct 20; 11(20):e4192. View Isolation and Culturing Primary Chaolangiocytes from Mouse Liver. Abstract

  38. A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. PLoS Genet. 2021 07; 17(7):e1009639. View A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. Abstract

  39. Lower oxygen saturation targets in preterm infants are not associated with increased rates of pulmonary hypertension. J Neonatal Perinatal Med. 2021; 14(4):519-526. View Lower oxygen saturation targets in preterm infants are not associated with increased rates of pulmonary hypertension. Abstract

  40. Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020944858. View Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response. Abstract

  41. Long-Term Fate of the Truncal Valve. J Am Heart Assoc. 2020 11 17; 9(22):e019104. View Long-Term Fate of the Truncal Valve. Abstract

  42. Prenatal duct closure leading to severe pulmonary hypertension in a preterm neonate-a case report. Cardiovasc Diagn Ther. 2020 Oct; 10(5):1691-1695. View Prenatal duct closure leading to severe pulmonary hypertension in a preterm neonate-a case report. Abstract

  43. Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol. 2020 07; 76(1):94-100. View Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. Abstract

  44. Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. J Am Med Inform Assoc. 2020 02 01; 27(2):294-300. View Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. Abstract

  45. Longitudinal Analysis of Ventilation Perfusion Mismatch in Congenital Diaphragmatic Hernia Survivors. J Pediatr. 2020 04; 219:160-166.e2. View Longitudinal Analysis of Ventilation Perfusion Mismatch in Congenital Diaphragmatic Hernia Survivors. Abstract

  46. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur Respir J. 2019 08; 54(2). View Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Abstract

  47. Standardized outcomes in reproductive cardiovascular care: The STORCC initiative. Am Heart J. 2019 11; 217:112-120. View Standardized outcomes in reproductive cardiovascular care: The STORCC initiative. Abstract

  48. Improving Safety of Intravenous Prostacyclin Administration to Pediatric Patients With Pulmonary Hypertension. Crit Care Nurse. 2019 Aug; 39(4):e1-e7. View Improving Safety of Intravenous Prostacyclin Administration to Pediatric Patients With Pulmonary Hypertension. Abstract

  49. Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension. Pulm Circ. 2019 Jul-Sep; 9(3):2045894019856471. View Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension. Abstract

  50. Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry. J Pediatr. 2019 08; 211:63-71.e6. View Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry. Abstract

  51. Feature extraction for phenotyping from semantic and knowledge resources. J Biomed Inform. 2019 03; 91:103122. View Feature extraction for phenotyping from semantic and knowledge resources. Abstract

  52. Pulmonary Artery Banding in Post-tricuspid Congenital Cardiac Shunting Defects with High Pulmonary Vascular Resistance. Pediatr Cardiol. 2019 Apr; 40(4):719-725. View Pulmonary Artery Banding in Post-tricuspid Congenital Cardiac Shunting Defects with High Pulmonary Vascular Resistance. Abstract

  53. The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension. J Pediatr. 2018 06; 197:17-22. View The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension. Abstract

  54. Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia. J Pediatr. 2017 09; 188:24-34.e1. View Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia. Abstract

  55. A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry. J Pediatr. 2017 09; 188:224-231.e5. View A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry. Abstract

  56. Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension. Circ Res. 2017 Aug 04; 121(4):341-353. View Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension. Abstract

  57. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr. 2016 Mar; 170:312-4. View Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. Abstract

  58. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24; 132(21):2037-99. View Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Abstract

  59. Lung Pathology in Pediatric Pulmonary Vein Stenosis. Pediatr Dev Pathol. 2016 May-Jun; 19(3):219-29. View Lung Pathology in Pediatric Pulmonary Vein Stenosis. Abstract

  60. Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension. Pulm Circ. 2015 Jun; 5(2):322-326. View Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension. Abstract

  61. Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. BMC Genomics. 2014 Dec 17; 15:1127. View Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. Abstract

  62. Response. Chest. 2014 Jun; 145(6):1439. View Response. Abstract

  63. Quality of life and parental adjustment in pediatric pulmonary hypertension. Chest. 2014 Feb; 145(2):237-244. View Quality of life and parental adjustment in pediatric pulmonary hypertension. Abstract

  64. Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child. Pediatrics. 2013 Dec; 132(6):e1699-703. View Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child. Abstract

  65. Right heart failure: toward a common language. J Heart Lung Transplant. 2014 Feb; 33(2):123-6. View Right heart failure: toward a common language. Abstract

  66. Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Int J Cardiol. 2013 Oct 03; 168(3):2435-40. View Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Abstract

  67. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7. View Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. Abstract

  68. Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med. 2013 Jan; 14(1):37-43. View Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Abstract

  69. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Am J Respir Crit Care Med. 2013 Mar 15; 187(6):572-5. View Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Abstract

  70. Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient. Pediatr Transplant. 2012 Dec; 16(8):E364-7. View Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient. Abstract

  71. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. Int J Cardiol. 2013 Mar 20; 164(1):106-10. View Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. Abstract

  72. Pulmonary arterial hypertension: what the large pulmonary arteries tell us. Pediatr Cardiol. 2011 Aug; 32(6):759-65. View Pulmonary arterial hypertension: what the large pulmonary arteries tell us. Abstract

  73. Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it? J Pediatr. 2010 Aug; 157(2):186-90. View Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it? Abstract

  74. Diagnostic strategies for acute presentation of pulmonary hypertension in children: particular focus on use of echocardiography, cardiac catheterization, magnetic resonance imaging, chest computed tomography, and lung biopsy. Pediatr Crit Care Med. 2010 Mar; 11(2 Suppl):S23-6. View Diagnostic strategies for acute presentation of pulmonary hypertension in children: particular focus on use of echocardiography, cardiac catheterization, magnetic resonance imaging, chest computed tomography, and lung biopsy. Abstract

  75. Lung abscess in adults with tetralogy of fallot and pulmonary atresia. Cardiol Young. 2010 Feb; 20(1):91-3. View Lung abscess in adults with tetralogy of fallot and pulmonary atresia. Abstract

  76. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. Arch Dis Child. 2009 Jul; 94(7):506-11. View Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. Abstract

  77. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population. Anesth Analg. 2008 Aug; 107(2):371-8. View The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population. Abstract

  78. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007 Dec; 120(6):1260-9. View Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Abstract

  79. Cardiovascular malformations in Fryns syndrome: is there a pathogenic role for neural crest cells? Am J Med Genet A. 2005 Dec 15; 139(3):186-93. View Cardiovascular malformations in Fryns syndrome: is there a pathogenic role for neural crest cells? Abstract

  80. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000 Dec 07; 343(23):1688-96. View Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. Abstract

  81. Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev. 1991 Apr; 5(4):642-55. View Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. Abstract

  82. Carcinogenic effects of monofunctional and bifunctional furocoumarins. Natl Cancer Inst Monogr. 1984 Dec; 66:205-10. View Carcinogenic effects of monofunctional and bifunctional furocoumarins. Abstract

English | Education

Undergraduate School

Mount Holyoke College

1983, South Hadley, MA

Medical School

Mount Sinai School of Medicine

1987, New York, NY

Internship

Floating Hospital for Children at Tufts

1988, New York, MA

Residency

Floating Hospital for Children at Tufts

1990, Boston, MA

Residency

Chief Resident

Floating Hospital for Children at Tufts

1991, Boston, MA

English | Publications

English | Education

Undergraduate School

University of North Carolina

1993, Chapel Hill, NC

Graduate School

MMSc

Harvard Medical School

2006, Boston, MA

Medical School

Wake Forest University

1997, Winston-Salem, NC

Internship

Floating Hospital for Children

1998, Boston, MA

Residency

Floating Hospital for Children

2001, Boston, MA

Fellowship

Critical Care Medicine

Boston Children's Hospital

2004, Boston, MA

English | Publications

English | Education

Undergraduate School

University of Notre Dame

1986, Notre Dame, IL

Medical School

MD

University of Michigan Medical School

1990, Ann Arbor, MI

Medical School

DMD

University of Pennsylvania School of Dental Medicine

1993, Philadelphia, PA

Graduate School

MBA

Melbourne Business School

2004, Melbourne, Australia

Internship

General Surgery

University of Michigan

1991, Ann Arbor, MI

Residency

Otolaryngology

Massachusetts Eye and Ear Infirmary

1997, Boston, MA

Residency

Plastic Surgery

Brigham & Women's Hospital / Boston Children's Hospital

1999, Boston, MA

Fellowship

Craniofacial Surgery

Royal Children's Hospital

2000, Melbourne, Australia

English | Publications

English | Education

Undergraduate School

Middlebury College

Middlebury, VT

Medical School

University of Massachusetts School of Medicine

Worcester, MA

Residency

University of Connecticut School of Medicine

Farmington, CT

English | Education

Undergraduate School

Yale College

New Haven, CT

Medical School

Yale University School of Medicine

New Haven, CT

Internship

University of Minnesota Hospital & Clinics

Minneapolis, MN

Residency

University of Minnesota Hospital & Clinics

Minneapolis, MN

Fellowship

University of Minnesota Hospital & Clinics

Minneapolis, MN

English | Publications

English | Education

Undergraduate School

Boston University

2000, Boston, MA

Medical School

Boston University

2004, Boston, MA

Internship

Caritas Carney Hospital

2005, Boston, MA

Residency

Boston Medical Hospital

2005, Boston, MA

Fellowship

Pediatric Ophthalmology and Adult Strabismus

Boston Children's Hospital

2009, Boston, MA

English | Publications

English | Education

Undergraduate School

Colgate University

2000, Hamilton, NY

Medical School

Yale School of Medicine

2005, New Haven, CT

Internship

Massachusetts General Hospital for Children

2006, Boston, MA

Residency

Massachusetts General Hospital for Children

2008, Boston, MA

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services